Paradigm-shifting studies have revealed that the heart contains heterogeneous and dynamic immune and stromal cell populations that are crucial determinants of health and disease. Advances in molecular imaging now make it possible to non-invasively visualize the cardiac cellular landscape in humans, providing a means to guide precision therapies.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Koenig, A. L. et al. Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. Nat. Cardiovasc. Res. 1, 263–280 (2022).
Zaman, R., Hamidzada, H. & Epelman, S. Exploring cardiac macrophage heterogeneity in the healthy and diseased myocardium. Curr. Opin. Immunol. 68, 54–63 (2021).
Bajpai, G. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med. 24, 1234–1245 (2018).
Thackeray, J. T. & Bengel, F. M. Molecular imaging of myocardial inflammation with positron emission tomography post-ischemia: a determinant of subsequent remodeling or recovery. JACC Cardiovasc. Imaging 11, 1340–1355 (2018).
Hess, A. et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur. Heart J. 41, 3564–3575 (2020).
Heo, G. S. et al. Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ. Res. 124, 881–890 (2019).
Heo, G. S. et al. Targeted PET imaging of chemokine receptor 2-positive monocytes and macrophages in the injured heart. J. Nucl. Med. 62, 111–114 (2021).
Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430–433 (2019).
Diekmann, J. et al. Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with magnetic resonance tissue characterization and subsequent functional outcome. J. Nucl. Med. https://doi.org/10.2967/jnumed.121.263555 (2022).
Heckmann, M. B. et al. Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease. Circ. Cardiovasc. Imaging 13, e010628 (2020).
K.J.L. is supported by grants from the National Institutes of Health (HL161185, HL150891 and HL151078), the Children’s Discovery Institute (PM-LI-2019-829), the Burroughs Welcome Fund (1014782), the Leducq Foundation (20CVD02) and by generous gifts through Washington University and Barnes Jewish Hospital. Y.L. is supported by grants from the National Institutes of Health (HL145212, HL150891, HL153436, HL151685 and EB025815).
K.J.L. serves as a consultant for Implicit Biosciences and Medtronic and is the recipient of sponsored research agreements with Amgen and Novartis. K.J.L. and Y.L. have a pending patent entitled “Methods for detecting CCR2 receptors” (application number: US17/001,857).
About this article
Cite this article
Lavine, K.J., Liu, Y. The dynamic cardiac cellular landscape: visualization by molecular imaging. Nat Rev Cardiol 19, 345–347 (2022). https://doi.org/10.1038/s41569-022-00702-z